Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626167 · ClinicalTrials.gov registry record · Early Phase 1
Concomitant Renal and Urinary Bladder Allograft Transplantation
A Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT04626167 is a Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04626167, a Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
Conditions Studied
Interventions
- PROCEDURE Concomitant Renal and Urinary Bladder Allograft Transplantation
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2026-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04626167
The ClinicalTrials.gov registry entry for NCT04626167 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Concomitant Renal and Urinary Bladder Allograft Transplantation is the first listed.
NCT04626167 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04626167 about?
NCT04626167 is a clinical study titled "Concomitant Renal and Urinary Bladder Allograft Transplantation". The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
What is the current status of trial NCT04626167?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2021-06-01. Estimated completion is 2026-01.
What conditions does trial NCT04626167 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Neurogenic Bladder, Transplant, Bladder Dysfunction, Bladder Outlet Obstruction.
What interventions are being tested in trial NCT04626167?
The interventions under investigation include: Concomitant Renal and Urinary Bladder Allograft Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04626167?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04626167 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
RECRUITING · Early Phase 1
-
Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
RECRUITING · Early Phase 1
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.